NVIDIA
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Nscale
9 Mar 2026
Nscale raises £1.5bn Series C led by Aker ASA and 8090 Industries to deploy AI infrastructure globally
Nscale designs and operates AI-native data centres, providing vertically integrated compute, networking and software infrastructure that addresses GPU shortages while delivering compliant, renewable-powered capacity for enterprise and national AI workloads.
Charm Therapeutics
2 Sept 2025
Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
Charm Therapeutics develops next generation cancer drugs designed to overcome treatment resistance, using an AI driven discovery platform to identify compounds for aggressive blood cancers such as AML.
NVIDIA
More venture news
- 9 Mar 2026
NscaleNscale raises £1.5bn Series C led by Aker ASA and 8090 Industries to deploy AI infrastructure globally
Series CAI - 29 Jan 2026
AutomataAutomata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models
Series CLife Sciences - 21 Nov 2024
LighthouseKKR leads £300m Series C for Lighthouse to accelerate AI-driven growth in the hospitality tech market
Series CHospitality